GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » Capital Expenditure

Coloplast AS (OCSE:COLO B) Capital Expenditure : kr-1,286.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Coloplast AS Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Coloplast AS's cash flow for capital expenditures for the three months ended in Jun. 2024 was kr-352 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2024 was kr-1,286.00 Mil.

Coloplast AS Capital Expenditure Historical Data

The historical data trend for Coloplast AS's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Capital Expenditure Chart

Coloplast AS Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -636.00 -931.00 -1,966.00 -1,135.00 -1,241.00

Coloplast AS Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -291.00 -384.00 -276.00 -274.00 -352.00

Coloplast AS Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1,286.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coloplast AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OCSE:COLO B) » Definitions » Capital Expenditure
Comparable Companies
OCSE:FFARMS OCSE:GJ OCSE:TGAMES OCSE:TIV OCSE:LUXOR B OCSE:CEMAT OCSE:TRIFOR OCSE:TCM OCSE:MATAS OCSE:PARKST A ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD WST XPAR:DIM TSE:4543 XSWX:STMN
Traded in Other Exchanges
CLPBY:USA CLPBF:USA COLOBc:UK 0QBO:UK CBHD:Germany
Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Website
https://www.coloplast.com
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines